NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Month: September 2024
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Transocean Ltd. (“Transocean” or the “Company”) (NYSE: RIG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Transocean Ltd. (“Transocean” or the “Company”) (NYSE: RIG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal (“BoM” or the “Company”) (NYSE: BMO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Sept. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal (“BoM” or the “Company”) (NYSE: BMO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…